Litcius/Paper detail

The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer

Alisha Bent, Shreya Raghavan, Arvind Dasari, Scott Kopetz

2022Clinical Colorectal Cancer25 citationsDOIOpen Access PDF

Topics & Concepts

MedicineColorectal cancerOncologyCirculating tumor DNAInternal medicineClinical trialAdjuvantAdjuvant therapyDiseaseMinimal residual diseaseProspective cohort studyStage (stratigraphy)CancerBiomarkerLynch syndromeDNA mismatch repairPaleontologyBiologyLeukemiaChemistryBiochemistryCancer Genomics and DiagnosticsGenetic factors in colorectal cancerColorectal Cancer Treatments and Studies
The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer | Litcius